PATTERNS OF INVASION AND PROBLEMS IN ASSESSMENT OF INVASION BY UROTHELIAL CARCINOMA. AP110 Urinary Bladder Biopsy Interpretation: Part 2

Size: px
Start display at page:

Download "PATTERNS OF INVASION AND PROBLEMS IN ASSESSMENT OF INVASION BY UROTHELIAL CARCINOMA. AP110 Urinary Bladder Biopsy Interpretation: Part 2"

Transcription

1 PATTERNS OF INVASION AND PROBLEMS IN ASSESSMENT OF INVASION BY UROTHELIAL CARCINOMA AP110 Urinary Bladder Biopsy Interpretation: Part 2 Mahul B. Amin, MD Director of Surgical Pathology, Emory University Hospital Professor of Pathology, Urology, Hematology & Oncology, Emory University School of Medicine Associate Director, Cancer Pathogenomics, Winship Cancer Institute 1364 Clifton Road, NE; Atlanta, GA Phone: (404) Fax: (404) mahul_amin@emory.org INTRODUCTION Here I will present the diagnostic criteria for invasion into lamina propria (pt 1 ) in urothelial cancer and illustrate histologic patterns of this process, which have also been the subject of a recent review. 1 Stage is the most powerful prognostic indicator in urothelial carcinoma, and a major defining parameter in the management of this disease. 1a The TNM staging system defines pt 1 tumors as those invading into the lamina propria, but not the muscularis propria 2. Although it has been demonstrated in several studies that pt 1 tumors bear a less favorable prognosis than pt a (non-invasive) neoplasms 3-6, clinically they are usually lumped together under the term superficial bladder tumors. Beside the fact that tumors classified in these two stages traditionally have been managed conservatively, another possible factor contributing to the clinicians rationale in grouping pt a and pt 1 tumors as superficial is the pathologists inability to always accurately recognize lamina propria invasion. On the contrary, those tumors with involvement of the muscularis propria and beyond (pt 2-4, or invasive tumors) are usually managed with aggressive surgical therapy (i.e. cystectomy). While an argument in favor of cystectomy for lamina propria invasive tumors of high grade has been made 7, 8, others have focussed on attempting to identify additional pathologic prognostic markers in lamina propria invasive disease (pt 1 ). This has made accurate histopathologic recognition of invasion into lamina propria even more important, and has inevitably raised an important question as to the best system to sub-stage pt 1 disease. I will further discuss the issue of substaging of pt 1 disease as well as some staging issues in bladder cancer. College of American Pathologists Materials are used with the permission of

2 NATURE OF THE SPECIMENS COMMONLY SUBMITTED FOR PATHOLOGIC EXAMINATION Most small bladder tumors (i.e. < 1 cm in size) can frequently be excised by cold cup biopsies. This procedure yields specimens in which the cellular architecture is mostly preserved, and in whom orientation is easier to maintain after embedding. The resulting H+E sections show the urothelial neoplasm, the lamina propria and superficial muscularis propria with orientation maintained, thus facilitating assessment of invasion. Larger tumors (>1cm) usually require hot loop resection ( transurethral resection of bladder tumor, or TURBT), in which the urologist attempts to include a generous sample of the underlying muscle layer to enable adequate pathologic staging. The specimens rendered by this procedure are often fragmented, heavily cauterized and difficult to orient. Sections from these specimens are usually fouled with thermal artifact, tangential sectioning, and disruption of the tumor architecture. While examining both types of specimens, it is important to note the presence or absence of muscularis propria, in order to assess involvement by neoplasia, and to provide feedback to the urologist regarding adequacy of resection. HISTOLOGY OF THE SUPERFICIAL BLADDER WALL The subepithelial connective tissue is a compact layer of fibrovascular connective tissue. In most instances it is divided by a thin layer of smooth muscle fibers (muscularis mucosae) into a lamina propia proper, which is superficial, and a submucosal layer, located between the muscularis mucosae and muscularis propia. It was not until recently that the muscularis mucosae layer of the urinary bladder was described 9-11, alerting pathologists and urologists of the importance of recognizing it and differentiating it from the underlying compact smooth muscle bundles of muscularis propria. Muscularis mucosae fibers are usually thin, often discontinuous, wispy and wavy fascicles of smooth muscle, which are frequently associated with large caliber blood vessels, and surrounded by loose fibroconnective tissue. Most studies have identified some degree of this layer in % of cystectomy specimens 10, 11, and in about a third of specimens from biopsies or TURBT 12, 13. Muscularis propria fascicles, on the other hand, are usually thick and compact, divided into distinct bundles surrounded by perimysium. Occasionally, muscularis mucosae bundles may undergo hypertrophy especially after biopsy or at the base of the tumor, and in such situations the distinction between muscularis mucosae and muscularis propria, especially in biopsy or TURBT specimens, may be difficult. AP110 Bladder Biopsy Pathology Part 2 2

3 DIAGNOSIS OF LAMINA PROPRIA INVASION Recognition of lamina propria invasion by urothelial carcinoma is occasionally one of the most challenging diagnoses in surgical pathology 14. Often faced with distorted, cauterized, and tangentially sectioned specimens, the pathologist should follow strict criteria to diagnose lamina propria invasion (Table 1). While evaluating tumors for invasion, it is important to focus in the following features: a) histologic grade of tumor, b) characteristics of the invading epithelium, c) the stromal response, d) the histologic pattern of invasion, and e) awareness of possible pitfalls. Histologic grade. Lamina propria invasion should be carefully looked for in all high-grade papillary carcinomas. While invasion is not necessarily an unexpected finding in low grade tumors, it is much more common in high grade lesions. In Jordan et al. s series 15, 96.5% of invasive carcinomas were grade III (1973 World Health Organization [WHO] classification). Similarly, of 53 patients with pt 1 disease in Malmström et al. s series 16, 37 (70%) were grades 2b and higher (modified Berkvist system), which roughly equate to the high grade papillary urothelial carcinomas of the 1998 World Health Organization/International Society of Urologic Pathology (WHO/ISUP) classification 17. Thus, while clear cut histologic signs of invasion are required for the diagnosis of invasion into lamina propria, the level of suspicion should be higher in those cases with a high histologic grade. Invading epithelium. The invasive front of the neoplasm may show one of several features: single cells or irregularly shaped nests of tumor within the stroma, architectural complexity not conforming to the usual regularity of papillary neoplasms, or an irregular, disrupted, or absent basement membrane. Sometimes tentacular or finger-like extensions can be seen arising from the base of the papillary tumor. Frequently the invading nests appear morphologically different from the cells at the base of the non-invasive component of the tumor, with more abundant cytoplasm and often with a higher degree of pleomorphism. Stromal response. The lamina propria may react to invasion in one or more of the following forms: i. Desmoplastic or sclerotic stroma: The stroma is cellular with spindled fibroblasts, variable collagenization, with or without inflammation. ii. Retraction artifact: In some cases, a retraction artifact that mimics vascular invasion is seen in tumors invading only superficially into the lamina propria. Often this finding is focal, and, in our opinion, is one of the early signs of invasion into lamina propria. It is especially conspicuous in the recently described micropapillary variant of urothelial carcinoma. 18 iii. Inflamed stroma: Invasion may elicit a brisk inflammatory response. The lamina propria is heavily infiltrated by numerous inflammatory cells that AP110 Bladder Biopsy Pathology Part 2 3

4 may obscure the interface between epithelium and stroma. This makes recognition of small nests or single cell invasion difficult to recognize. iv. Myxoid stroma: Loose and hypocellular stroma with a myxoid background may occasionally be seen in some cases of invasive urothelial carcinomas. v. Pseudosarcomatous stroma: Sometimes the tumor induces an exuberant spindle cell response, with proliferation of fibroblasts that may display significant, often alarming cellular atypia. This feature, although helpful in assessing for invasion, should not be mistaken for the spindle cell component of a biphasic sarcomatoid urothelial cancer. The proliferating stroma is usually nonexpansile, being limited to areas around the neoplasm, and is cytologically composed of cells which have a degenerate or smudged appearance on high-power examination. vi. Absent stromal response: Frequently the stromal response to invading carcinoma may be absent. In these cases, as mentioned above, diagnosis of invasion should rely on the characteristics of the invading epithelium. HISTOLOGIC PATTERNS OF LAMINA PROPRIA INVASION Lamina propria invasive tumors may be classified from their morphologic perspective according to several patterns (Table 2). Awareness of these patterns may be important to the surgical pathologist in order to focus on particular areas of the tumor while assessing for invasion, thus facilitating its recognition, even when it is extremely focal. Not all patterns are associated with clinical significance. Carcinoma in situ (CIS) with microinvasion. Isolated or de novo CIS (i.e. in the absence of papillary and/or invasive neoplasm) is rare, representing approximately 1% of bladder neoplasms 19. Microinvasion by CIS is defined by Farrow et al. 6 as an invasive component measuring less than 5 mm in depth. In their study, these authors found microinvasion in 34% of a series of entirely submitted bladders harboring CIS, and in 5.8% of these cases metastatic disease developed, causing the patients demise. Their data suggest that microinvasion confers the ability to metastasize and cause death in a small number of cases. Amin et al. 20 have proposed that the 5 mm criterion may be liberal, and suggest a 2 mm cutoff for this diagnosis. The clinicopathologic significance of this finding needs to be determined. 20a Papillary urothelial carcinoma with microinvasion. Microinvasion of papillary tumors can be similarly defined as in cases with CIS, and should be mentioned in the diagnosis, in order to document minimal, focal or early invasion. AP110 Bladder Biopsy Pathology Part 2 4

5 Papillary urothelial carcinoma with invasion into stalk. Very rarely papillary urothelial carcinomas may invade into the stalk of a tumor. 20b Appreciation of this pattern requires optimal orientation of the entire papillary tumor, which may not always be the case, especially in TURBT specimens. Well-established invasion into underlying lamina propria. In the overwhelming majority of cases, invasion is seen at the base of the papillary neoplasm. With respect to the muscularis mucosae layer within the lamina propria, invasive tumors may be classified as follows: i. Invasive up to the muscularis mucosae ii. Invasive beyond the muscularis mucosae (into the submucosa), but not in the muscularis propria. iii. Lamina propria invasion not further specified (no muscularis mucosae present). This classification may in fact have clinical implications, as I will present below. Urothelial carcinoma with endophytic or broad front growth pattern. A more controversial pattern, and certainly a problematic one while assessing for invasion, is seen in large papillary tumors which display a prominent endophytic growth, and thus invade the lamina propria with a pushing border, much akin to cutaneous and mucosal verrucous carcinoma. 20 Unless this pattern is accompanied by true destructive stromal invasion (as defined above), the likelihood of metastasis in tumors with this histology is minimal, because the basement membrane is not truly breached. Another form of endophytic growth is when the carcinoma has a basic inverted architecture-like inverted papilloma of the bladder but has clear-cut cytologic atypia placing it into the carcinoma category. The distinguishing features are summarized in Table 3. PROBLEMS AND PITFALLS IN THE DIAGNOSIS OF pt 1 INVASION Diagnosis of lamina propria invasion is often difficult, and the problem is well exemplified in the data from the French Association of Urology Cancer Committee study 21, which revealed that seven experienced pathologists could agree on lamina propria invasion in only 61% of cases after 3 assessments. In 10% of cases, no consensus was achieved despite four evaluations. In another study by Abel et al. 22, 15% of lesions initially diagnosed as pt 1 were downstaged to pt a, and 22% of urothelial carcinomas diagnosed with muscle invasion were downstaged to pt 1 or pt a by a dedicated pathologist. In order to improve the concordance rates among pathologists, it is imperative to be aware and understand the possible pitfalls in the diagnosis of lamina propria invasion (Table 4). 22a The most common ones follow. Tangential sectioning and poor orientation. Transurethral resection of bladder tumor specimens are excised in a piecemeal fashion. This renders fragmented specimens, which are usually poorly oriented. Furthermore, due to their complex architecture, papillary tumors are inevitably tangentially AP110 Bladder Biopsy Pathology Part 2 5

6 sectioned in multiple planes, resulting in isolated nests of tumor cells within connective tissue. Smooth, round, and regular contours favor tangential sectioning, whereas irregular, jagged nests with haphazard arrangement favors stromal invasion. Thermal injury. Thermal injury or cautery artifact produces severely distorted morphology in TURBT specimens, and is a frequent source of distress for the pathologist. Unfortunately, pathologists have no control over this problem, although deeper levels may occasionally display better preserved areas. When this is not helpful, the pathologist should express the inability to render a definitive diagnosis due to thermal effect. Obscuring inflammation. Papillary tumors may show variable, often brisk inflammation at the tumor-stromal interface, which may obscure isolated cells or nests of invasive tumor. CIS involving von Brunn s nests. Flat lesions, when they involve von Brunn s nests may mimic lamina propria invasion by the mere presence of high-grade cells in a submucosal location. This is especially problematic in prominent nests or those that have been distorted by an inflammatory process. Muscle invasion indeterminate for type of muscle. In these cases invasive tumor is seen juxtaposed to muscle fibers, but due to obscuring factors (i.e. inflammation, tangential sectioning, cautery artifact, strong desmoplastic response, or poor orientation), the pathologist is unable to determine whether the muscle involved belongs to the muscularis mucosae or the muscularis propria. It is recommended that when faced with this situation, the pathologist should clearly state their uncertainty in establishing the depth of invasion, rather than to commit to a particular type of muscle involvement - muscularis mucosae (pt 1 ) or muscularis propria (pt 2 ). This distinction is critical, as muscularis propria invasion is currently regarded as the crossroads between conservative management and aggressive therapy. Invasion into fat does not indicate extravesical spread. Fat may be normally present in the lamina propria, therefore, tumor invasive into fat should not automatically equate to involvement of perivesical fat. 22b Deceptively bland variants of urothelial carcinomas. When limited to the lamina propria, deceptively bland patterns of invasive urothelial carcinoma may make the recognition of pt 1 disease extremely difficult. For example, microcystic urothelial carcinoma 23 can easily mimic cystitis cystica, and the recently described nested pattern may be easily confused with von Brunn s nests 24. Attention should be paid to general features useful in assessing invasion, such as cytologic atypia, infiltrative architecture, desmoplasia and architectural complexity, especially since they may be subtle in superficial biopsies. AP110 Bladder Biopsy Pathology Part 2 6

7 Overdiagnosis of vascular invasion. As mentioned earlier, a peculiar stromal retraction artifact in lamina propria invasive tumors may mimic vascular invasion. Caution is hence warranted and strict criteria should be used (Table 5). Applying strict morphologic criteria for the diagnosis of lamina propria invasion should minimize diagnostic discrepancies among pathologists. Admission of the inability to definitively identify invasion is appropriate in difficult cases with suboptimal tissue preservation or orientation. SUBSTAGING OF pt 1 DISEASE Several studies have evaluated the issue of substaging pt 1 urothelial carcinomas (Table 6). Most of them use the muscularis mucosae as an anatomic landmark to assess the depth of invasion. In the absence of muscularis mucosae (seen in 18-83% TURBT specimens only), large vessels may be used as a substitute for muscularis mucosae. Others have divided cases between those tumors that involve the stromal core of the papillae and those that invade the lamina propria proper. 20b In 1990 Younes et al. 25 found a 75% all-cause 5-year survival for tumors invading above or into the muscularis mucosae, compared to a 11% survival for those tumors invading below the muscularis mucosae. Similarly, Hasui et al. 26, Angulo et al. 12, and Holmang et al. 27 were able to find different progression rates, 5-year all-cause survival, and cancer specific survival, respectively, for those tumors with invasion above and below the muscularis mucosae. In 1998, Hermann et al. 28 found that tumors with invasion beyond the muscularis mucosae had a worse prognosis than those with invasion in the tumor stalk or above the muscularis mucosae. In a multivariate analysis, depth of invasion was the only significant parameter that predicted outcome. The main problem with this method of substaging pt 1 urothelial carcinomas is that the muscularis mucosae, as mentioned before, is not a consistent histologic finding in bladder tumor resection specimens. Most of the above mentioned authors have at least partially overcome this problem by using the large blood vessels in the submucosa as a substitute anatomical landmark when muscularis mucosae was not present. For example, Angulo et al. 12 were able to identify muscularis mucosae in 39% of their cases, and used the blood vessels landmark in a remaining 26%. Thus, in 35% of their cases, substaging could not be performed. Platz et al. 13 identified muscularis mucosae in only 33% of their cases and Sozen et al in 55% of cases. 28b Furthermore, by using the same substitute anatomical landmark in the rest of the cases, they did not find any prognostic significance in substaging pt 1 disease. These realistic problems, which are probably encountered not infrequently in everyday practice, have prompted recent questioning of the validity of substaging pt 1 disease based on the muscularis mucosae. In 1999, Cheng et al. 29 proposed a system of substaging pt 1 tumors based on the micrometrical measurement of the depth of invasion. They studied a series of 55 patients with stage T 1 urothelial carcinomas diagnosed on TURBT specimens and eventually treated by cystectomy. By using a micrometer to measure the depth of invasion from the mucosal basement membrane, they found a significant correlation between depth of AP110 Bladder Biopsy Pathology Part 2 7

8 invasion in the TURBT specimen and final pathologic stage on cystectomy. By using 1.5 mm of depth of invasion, they were able to predict advance stage in the cystectomy with a sensitivity of 81%, a specificity of 83%, and a positive and negative predictive value of 95% and 56%, respectively. The collective data implies that deep lamina propria (i.e. submucosal) invasion, whether assessed by the relation of the tumor to the muscularis mucosae, or by direct micrometric measurement, identifies a subset of patients with pt 1 disease with a more adverse prognosis. In Younes data 25, the 5-year survival of patients with pt 1c disease (i.e. invasion beyond the muscularis mucosae) was similar to those with pt 2 disease (14% vs. 20%, respectively). The recent WHO/ISUP Consensus Conference Committee recognized and encouraged the need to express some assessment of the degree or extent of invasion in the pathology report; however, at this point it is felt that substaging of pt 1 tumors should not be universally adopted, due to the above-mentioned unresolved issues. 17,33 CONCLUDING REMARKS In summary, the aggregate data on superficial bladder neoplasms seem to suggest that grouping of pt 1 tumors with pt a tumors, together into the category of superficial urothelial neoplasia, is not entirely appropriate. Although their treatment and follow-up is often similar, their biologic potential is different, with reported progression rates for pt 1 disease ranging from 22% to 53%. Invasion into the lamina propria, whether occurring in CIS or papillary neoplasia, confers the ability to metastasize and cause death; hence, strict criteria should be applied when assessing for presence of invasion. In addition, lamina propria invasive tumors have a higher risk of recurrence and disease progression, requiring closer clinical surveillance. Further study is required to fully evaluate the significance of substaging of pt 1 tumors and the most appropriate method, which can be reliably practiced by the surgical pathologist to document the extent and depth of invasion. AP110 Bladder Biopsy Pathology Part 2 8

9 Table 1 Criteria for Diagnosis of Invasion into Lamina Propria by Urothelial Carcinoma Histologic grade: Invasion seen much more frequently, although not exclusively, in high grade (1998 WHO/ISUP classification) lesions. Invading epithelium: Irregularly shaped nests Single cell infiltration Irregular or absent basement membrane Tentacular finger-like projections Invasive component with higher nuclear grade and/or more cytoplasm (or morphologically different) than overlying non-invasive component Stromal response: Desmoplasia or sclerosis Retraction artifact Inflammation Myxoid stroma Pseudosarcomatous stroma Absent stromal response WHO/ISUP= World Health Organization/International Society of Urologic Pathology Consensus Classification of Bladder tumors Table 2 Histologic Patterns of Invasion into Lamina Propria by Urothelial Carcinoma Carcinoma in situ with microinvasion Papillary urothelial carcinoma with microinvasion Papillary urothelial carcinoma with invasion into stalk Well-established invasion into lamina propria Invasion up to muscularis mucosae Invasion beyond muscularis mucosae Lamina propria invasion not further specified (no muscularis mucosae present) Urothelial carcinoma with endophytic or broad front growth pattern with destructive stromal invasion AP110 Bladder Biopsy Pathology Part 2 9

10 Table 3 Differences between inverted papilloma and TCC with inverted papilloma-like growth. Surface Growth Pattern Inverted Papilloma Smooth dome shaped or focally exophytic, cytologically unremarkable, usually intact surface. Endophytic expansile sharply delineated lesion. TCC with Inverted Papilloma-like growth Variable, usually exophytic papillary lesion. Endophytic, may coexist with broad front inverted growth pattern, lesional circumscription variable. Cytologic Features Biologic Potential Ramifying cords and trabeculae of even width. Destructive invasion of lamina propria or muscularis propria absent by definition. Orderly polarized cells with tendency to spindle and palisade at the periphery. Diffuse and severe cytologic atypia absent. Benign (From ref 20 Amin et al) Ramifying cords and trabeculae with irregularity of width and with transition into solid areas. Invasion into lamina propria or muscle may be present. Maturation, spindling or palisading minimal to absent. Cytologic features are grade dependent (urothelial carcinoma, low grade or high grade). Recur (usually new occurrences) or progress (depends on grade and stage) AP110 Bladder Biopsy Pathology Part 2 10

11 Table 4 Pitfalls in the diagnosis of lamina propria invasion by urothelial carcinoma Tangential sectioning Thermal artifact Obscuring inflammation Carcinoma in situ involving von Brunn s nests Invasion into muscle, indeterminate for type of muscle (muscularis mucosae vs. muscularis propria) Invasion into adipose tissue within lamina propria (overdiagnosis of extravesical invasion) Deceptively bland urothelial carcinomas Microcystic variant of urothelial carcinoma (invasive) Broad front or inverted growth raising the question of invasion Nested variant of urothelial carcinoma (invasive) Overdiagnosis of vascular invasion Table 5 Criteria And Pitfalls For Vascular-Lymphatic Invasion In Urothelial Neoplasms. Criteria For Vascular-Lymphatic Invasion Presence of unequivocal endothelial lining Nests attached to wall of lumen containing blood constituents (red blood cells, inflammatory cells or thrombus) Nests attached to and conforming to the shape of the vessel Peritumoral location of vascular invasion (not intratumoral invasion) Tumor cells in the space near large artery or vein (vascular route) Immunohistochemical confirmation (Factor VIII, Ulex europaeus, or CD31) Pitfalls In Recognition Of Vascular-Lymphatic Invasion Pitfall in recognition of endothelial/venular spaces - Retraction of stroma (particularly conspicuous in micropapillary tumors) Pitfall in recognition of large vessel invasion - Carry-over due to fragmentation of neoplasm (From ref 14 Amin et al) AP110 Bladder Biopsy Pathology Part 2 11

12 Table 6 Proposed Substaging Systems for pt1 Urothelial Carcinoma Authors Substaging system Outcom e Panago et al. 20b T1a: Invasion into papillary core 82% T1b: Lamina propria invasion 83% Younes et al. 25 T1a: Invasion above muscularis mucosae 75% T1b: Invasion at muscularis mucosae T1c: Invasion below muscularis mucosae 11% Hasui et al. 26 T1a: Invasion above muscularis mucosae 7% T1b: Invasion below muscularis mucosae 54% Angulo et al. 12 T1a: Invasion above or at muscularis mucosae 86% T1b: Invasion below muscularis mucosae 52% Platz et al. 13 T1a: Invasion above muscularis mucosae 65% T1b: Invasion at muscularis mucosae 54% T1c: Invasion below muscularis mucosae 60% Holmang et al. 27 T1a: Invasion above muscularis mucosae 23% T1b: Invasion at or below muscularis mucosae 45% Hermann et al. 28 T1a: Invasion limited to stalk of papillae 78% T1b: Invasion above muscularis mucosae 75% T1c: Invasion at or below muscularis mucosae 55% Cheng et al. 29 Depth of invasion measured by micrometer <1.5 mm 44% >1.5 mm 95% Sozen et al. 28b T1a: Invasion above muscularis mucosae NA T1b: Invasion below muscularis mucosae NA Modified from Cheng et al 29 and Jimenez et al 1 Endpoint Recurrence free rate 5 year all-cause survival Progression rate 5-year all-cause survival 10-year cancerspecific survival Diseasespecific demise 5-year all cause survival Prediction of pt 2+ disease Stage statistically significant References: 1. Jimenez RE, Keane TE, Hardy HT, Amin, MB: pt 1 Urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol 2000; 7: a. Mazzucchelli L, Bacchi M, Studer UE, Markwalder R, Sonntag RW, Kraft R: Invasion depth is the most important prognostic factor for transitional- cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy. Int J Cancer 1994; 57: American Joint Commission on Cancer. AJCC cancer staging manual. 5 ed. 1997: Lippincott-Raven. 302pp. 3. Anderstrom C, Johansson S, Nilsson S: The significance of lamina propria invasion on the prognosis of patients with bladder tumors. J Urol 1980; 124: Williams JL, Hammonds JC, Saunders N: T1 bladder tumours. Br J Urol 1977; 49: AP110 Bladder Biopsy Pathology Part 2 12

13 5. Kiemeney LA, Witjes JA, Verbeek AL, Heijbroek RP, Debruyne FM: The clinical epidemiology of superficial bladder cancer. Dutch South- East Cooperative Urological Group. Br J Cancer 1993; 67: Farrow GM, Utz DC: Observations on microinvasive transitional cell carcinoma of the urinary bladder. Clin Oncol 1982; 1: Esrig D, Freeman JA, Stein JP, Skinner DG: Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder. Semin Urol Oncol 1997; 15: Takashi M, Sakata T, Murase T, Hamajima N, Miyake K: Grade 3 bladder cancer with lamina propria invasion (pt1): characteristics of tumor and clinical course. Nagoya J Med Sci 1991; 53: Dixon JS, Gosling JA: Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 1983; 136: Ro JY, Ayala AG, el-naggar A: Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 1987; 11: Keep JC, Piehl M, Miller A, Oyasu R: Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 1989; 91: Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M: Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995; 45: Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF: Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996; 9: Amin MB, Murphy WM, Reuter VE, Weiss MA, Ro JY, Ayala AG, Eble JN, Young RH: Controversies in the pathology of transitional cell carcinoma of the urinary bladder. Part II. In: Rosen PP and Fechner RE, eds. Reviews of Pathology. Chicago: ASCP Press,1997: Jordan AM, Weingarten J, Murphy WM: Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 1987; 60: Malmstrom PU, Busch C, Norlen BJ: Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 1987; 21: AP110 Bladder Biopsy Pathology Part 2 13

14 17. Epstein JI, Amin MB, Reuter VR, Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: Amin MB, Ro JY, el-sharkawy T, Lee KM, Troncoso P, Silva EG, Ordonez NG, Ayala AG: Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994; 18: Orozco RE, Martin AA, Murphy WM: Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis. Cancer 1994; 74: Amin MB, Gomez JA, Young RH: Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997; 21: a. McKenney J, Gomez JA, Desai S, Lee MW, Amin MB: Morphologic expressions of urothelial carcinoma in situ. A detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 2001; 25: b. Pagano F, PegoraroV, Prayer-Galetti T et al: Prognosis of bladder cancer-ii. The fate of patients with T 1b transitional cell bladder cancer. Eur Urol 1987; 13: Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pta vs pt1): recommended approach. Pathologists of the French Association of Urology Cancer Committee. World J Urol 1993; 11: Abel PD, Henderson D, Bennett MK, Hall RR, Williams G: Differing interpretations by pathologists of the pt category and grade of transitional cell cancer of the bladder. Br J Urol 1988; 62: a. Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O, Ogreid P: Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003; 169: b. Philip AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JY: Intravesical adipose tissue. A quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol 2000; 24: Young RH, Zukerberg LR: Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol 1991; 96: AP110 Bladder Biopsy Pathology Part 2 14

15 24. Drew PA, Furman J, Civantos F, Murphy WM: The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996; 9: Younes M, Sussman J, True LD: The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990; 66: Hasui Y, Osada Y, Kitada S, Nishi S: Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994; 43: Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL: The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800-3; discussion Hermann GG, Horn T, Steven K: The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998; 159: b. Sozen S, Akbal C, Sokmensuer C, Ekici S, Ozen H: Microstaging of pt1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pt1 subcategory). Urol Int 2002; 69: Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG: Substaging of T1 Bladder Carcinoma based on the depth of invasion: A New Proposal. Cancer 1999; 86: Kaubisch S, Lum BL, Reese J, Freiha F, Torti FM: Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 1991; 146: Larsen MP, Steinberg GD, Brendler CB, Epstein JI: Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 1990; 3: Ramani P, Birch BR, Harland SJ, Parkinson MC: Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pt1 transitional carcinoma of bladder. Histopathology 1991; 19: Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP Jr: Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004; 22: AP110 Bladder Biopsy Pathology Part 2 15

Jesse K. McKenney, MD

Jesse K. McKenney, MD Jesse K. McKenney, MD Outline Microscopic anatomy of the urinary bladder Diagnosing invasion Subtle patterns (variants) of carcinoma Clinically important variants of carcinoma Microanatomy of Bladder Initial

More information

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1)

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1) Pathologic Assessment of Invasion in TUR Specimens A. Lopez-Beltran T1 (ct1) 1 Prognostic factors for progression/invasive disease Ta,T1,CIS- NMIBC :TNM 2017 ESSENTIAL: Grade T stage CIS Number of lesions

More information

Case Presentation 58 year old male with recent history of hematuria, for which he underwent cystoscopy. A 1.5 cm papillary tumor was found in the left lateral wall of the bladder. Pictures of case Case

More information

BLADDER CANCER EPIDEMIOLOGY

BLADDER CANCER EPIDEMIOLOGY BLADDER CANCER WHAT IS NEW AND CLINICALLY RELEVANT Canadian Geese - Geist Reservoir (my backyard), Indianapolis, USA BLADDER CANCER EPIDEMIOLOGY Urinary bladder 17,960 2% Urinary bladder 4,390 1.6% Siegel

More information

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I. Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a

More information

AP110 URINARY BLADDER BIOPSY INTERPRETATION Part 1

AP110 URINARY BLADDER BIOPSY INTERPRETATION Part 1 AP110 URINARY BLADDER BIOPSY INTERPRETATION Part 1 Mahul B. Amin, MD Director of Surgical Pathology, Emory University Hospital Professor of Pathology, Urology, Hematology & Oncology, Emory University School

More information

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections european urology supplements 8 (2009) 453 457 available at www.sciencedirect.com journal homepage: www.europeanurology.com 2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms:

More information

Urinary Bladder, Ureter, and Renal Pelvis

Urinary Bladder, Ureter, and Renal Pelvis Urinary Bladder, Ureter, and Renal Pelvis Protocol applies to all carcinomas of the urinary bladder, ureter, and renal pelvis. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Procedures

More information

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction

More information

Value of Immunohistochemistry in StagingT1 Urothelial Bladder Carcinoma

Value of Immunohistochemistry in StagingT1 Urothelial Bladder Carcinoma European Urology European Urology 42 (2002) 459±463 Value of Immunohistochemistry in StagingT1 Urothelial Bladder Carcinoma Paulette Mhawech a,*, Christophe Iselin b, Marie-FrancËoise Pelte a a Pathologie

More information

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification

More information

Carcinoma of the Urinary Bladder Histopathology

Carcinoma of the Urinary Bladder Histopathology Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

Pathology of bladder cancer in Egypt; a current study.

Pathology of bladder cancer in Egypt; a current study. Pathology of bladder cancer in Egypt; a current study. Thesis Submitted for partial fulfillment of Master degree in urology By Mohamed Atef Mohamed Ahmed M.B.B.CH Supervised by Prof.Dr.: Omar Mohamed Abdel-

More information

TOPICS FOR DISCUSSION

TOPICS FOR DISCUSSION INTERNATIONAL SOCIETY OF UROLOGIC PATHOLOGY PATHOLOGIC STAGING OF SELECT UROLOGIC MALIGNANCIES Mahul B. Amin, MD Professor and Chairman Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los

More information

Staging and Grading Last Updated Friday, 14 November 2008

Staging and Grading Last Updated Friday, 14 November 2008 Staging and Grading Last Updated Friday, 14 November 2008 There is a staging graph below Blood in the urine is the most common indication that something is wrong. Often one will experience pain or difficulty

More information

The pathology of bladder cancer

The pathology of bladder cancer 1 The pathology of bladder cancer Charles Jameson Introduction Carcinoma of the bladder is the seventh most common cancer worldwide [1]. It comprises 3.2% of all cancers, with an estimated 260 000 new

More information

Unknown Slides Conference

Unknown Slides Conference Unknown Slides Conference Jae Y. Ro, MD, PhD Weill Medical College of Cornell Univ. The Methodist Hospital, and UT MD Anderson Cancer Center Houston, TX November 9, 2013 Amman, Jordan 25 th Congress of

More information

AP Slide Seminar: Tumors and Tumor-like Lesions of the Urinary Bladder. David Grignon MD, FASCP

AP Slide Seminar: Tumors and Tumor-like Lesions of the Urinary Bladder. David Grignon MD, FASCP 5 2011 AP Slide Seminar: Tumors and Tumor-like Lesions of the Urinary Bladder David Grignon MD, FASCP 2011 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 1600 Chicago,

More information

Radical Cystectomy Often Too Late? Yes, But...

Radical Cystectomy Often Too Late? Yes, But... european urology 50 (2006) 1129 1138 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Radical Cystectomy Often Too Late? Yes, But... Urs E. Studer

More information

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein. 1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological

More information

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone

More information

Normal Morphology. Anatomic Considerations. Normal Urothelial Histology and Cytology

Normal Morphology. Anatomic Considerations. Normal Urothelial Histology and Cytology 1 Normal Morphology Anatomic Considerations The urinary tract can be divided into three regions: the kidney; the calyces, pelves and ureters (upper collecting system or upper tract); and the bladder and

More information

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy.

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy. Tumori, 96: 699-703, 2010 Influence of stage discrepancy on outcome in patients treated with radical cystectomy Ja Hyeon Ku 1, Kyung Chul Moon 2, Cheol Kwak 1, and Hyeon Hoe Kim 1 1 Department of Urology,

More information

MEDitorial March Bladder Cancer

MEDitorial March Bladder Cancer MEDitorial March 2010 Bladder Cancer Last month, my article addressed the issue of blood in the urine ( hematuria ). A concerning cause of hematuria is bladder cancer, a variably malignant tumor starting

More information

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Jpn J Clin Oncol 2002;32(11)461 465 Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Takashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, Ryoji Arata,

More information

A215- Urinary bladder cancer tissues

A215- Urinary bladder cancer tissues A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90

More information

Update on bladder neoplasia: 2016 WHO classification and recent developments within the pathologic, molecular & clinical domains of the disease

Update on bladder neoplasia: 2016 WHO classification and recent developments within the pathologic, molecular & clinical domains of the disease Update on bladder neoplasia: 2016 WHO classification and recent developments within the pathologic, molecular & clinical domains of the disease Biology of urothelial tumorigenesis: insights from genetically

More information

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as

More information

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017 Update on staging colorectal carcinoma, the 8 th edition AJCC Dale C. Snover, MD November 3, 2017 General overview of staging Reason for uniform staging Requirements to use AJCC manual and/or CAP protocols

More information

Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors

Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors Romanian Journal of Morphology and Embryology 2006, 47(2):175 179 ORIGINAL PAPER Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors E. TRAŞCĂ 1), R.

More information

Papillary Lesions of the Breast: WHO Update

Papillary Lesions of the Breast: WHO Update Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast

More information

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy. 30 th Congress of the European Society of Pathology Tuesday, September 11, 2018 The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

More information

International Society of Gynecological Pathologists Symposium 2007

International Society of Gynecological Pathologists Symposium 2007 International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade

More information

Update on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual

Update on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual Update on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual Rajal B. Shah, M.D. Director, Urologic Pathology SHAHR6@ccf.org @rajalbshah

More information

American Journals of Cancer Case Reports. A Rare Case of Rectal Metastasis from Sarcomatoid Variant of Urothelial Carcinoma: A Case Report

American Journals of Cancer Case Reports. A Rare Case of Rectal Metastasis from Sarcomatoid Variant of Urothelial Carcinoma: A Case Report American Journals of Cancer Case Reports Lin JYJ et al. American Journals of Cancer Case Reports 2014, 3:1-5 http://ivyunion.org/index.php/ajccr Page 1 of 5 Vol 3 Article ID 20140539, 5 pages Case Report

More information

Papillary Lesions of the breast

Papillary Lesions of the breast Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic

More information

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o

More information

Urinary Bladder, Ureter, and Renal Pelvis

Urinary Bladder, Ureter, and Renal Pelvis Urinary Bladder, Ureter, and Renal Pelvis Protocol applies to all carcinomas of the urinary bladder, ureter, and renal pelvis. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Procedures

More information

55 Important pathologic parameters in reporting urothelial carcinoma of the bladder. Jesse McKenney MD

55 Important pathologic parameters in reporting urothelial carcinoma of the bladder. Jesse McKenney MD 55 Important pathologic parameters in reporting urothelial carcinoma of the bladder Jesse McKenney MD 2011 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 1600 Chicago,

More information

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive

More information

Low-grade serous neoplasia. Robert A. Soslow, MD

Low-grade serous neoplasia. Robert A. Soslow, MD Low-grade serous neoplasia Robert A. Soslow, MD soslowr@mskcc.org Outline Orientation Ovarian tumor overview Non serous borderline tumors Serous borderline tumors Clinical summary Morphologic description

More information

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens ISPUB.COM The Internet Journal of Pathology Volume 12 Number 1 Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens C Rose, H Wu Citation C Rose, H Wu.. The Internet Journal of Pathology.

More information

Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder

Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder Version: UrinaryBladder 4.0.1.1 Protocol Posting Date: February 2019 CAP Laboratory Accreditation

More information

A Personal History NIH CWRU U of TN U of Miami Animal Model for Bladder Cancer Carcinogen induced FANFT Three Models Primary tumors individual tumors, simulates clinical scenario of locally advanced cancer

More information

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships Staging and Reporting of Prostate Cancer: Major Changes in 8 th Edition AJCC Staging and CAP Cancer Checklists USCAP requires that all planners (Education

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual

More information

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells 2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT) Bladder Case 1 February 17, 2007 Specimen (s) received: Bladder Tumor Pre-operative Diagnosis: Bladder Cancer Post operative Diagnosis: Bladder Cancer Procedure: Cystoscopy, transurethral resection of

More information

04/09/2018. Squamous Cell Neoplasia and Precursor Lesions. Agenda. Squamous Dysplasia. Squamo-proliferative lesions. Architectural features

04/09/2018. Squamous Cell Neoplasia and Precursor Lesions. Agenda. Squamous Dysplasia. Squamo-proliferative lesions. Architectural features Squamous Cell Neoplasia and Precursor Lesions Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical

More information

The quintessential role of the surgical pathologist in

The quintessential role of the surgical pathologist in ORIGINAL ARTICLE Diagnostic Utility of Antibody to Smoothelin in the Distinction of Muscularis Propria From Muscularis Mucosae of the Urinary Bladder A Potential Ancillary Tool in the Pathologic Staging

More information

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires

More information

Protocol for the Examination of Specimens from Patients with Carcinoma of the Urinary Bladder

Protocol for the Examination of Specimens from Patients with Carcinoma of the Urinary Bladder Protocol for the Examination of Specimens from Patients with Carcinoma of the Urinary Bladder Protocol applies primarily to invasive and noninvasive carcinomas, including carcinoma in situ. Version: Protocol

More information

A Review of Outcomes for Stage Ta Bladder Tumors

A Review of Outcomes for Stage Ta Bladder Tumors AJCP /ORIGINAL ARTICLE A Review of Outcomes for Stage Ta Bladder Tumors Robin T. Vollmer, MD From the VA and Duke University Medical Centers, Durham, NC. Key Words: Urothelial tumors; Tumor grade; Outcomes;

More information

Staging and reporting of urothelial carcinoma of the urinary bladder

Staging and reporting of urothelial carcinoma of the urinary bladder & 2009 USCAP, Inc All rights reserved 0893-3952/09 $32.00 www.modernpathology.org Staging and reporting of urothelial carcinoma of the urinary bladder Liang Cheng 1,2, Rodolfo Montironi 3, Darrell D Davidson

More information

Carcinoma of the Renal Pelvis and Ureter Histopathology

Carcinoma of the Renal Pelvis and Ureter Histopathology Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

Urothelial carcinoma is the most common tumor in the

Urothelial carcinoma is the most common tumor in the Micropapillary Variant of Urothelial Carcinoma in the Upper Urinary Tract A Clinicopathologic Study of 11 Cases Charles C. Guo, MD; Pheroze Tamboli, MD; Bogdan Czerniak, MD, PhD Context. Micropapillary

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urethra and Periurethral Glands

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urethra and Periurethral Glands Protocol for the Examination of Specimens From Patients With Carcinoma of the Urethra and Periurethral Glands Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition,

More information

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4). GU Cancer Staging: Updates and Challenging Areas 13 th Current Issues in Surgical Pathology San Francisco, CA June 5, 2010 Jeffry P. Simko, PhD, MD Associate Professor Departments of Urology and Anatomic

More information

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose Tumor Budding in Colorectal Carcinoma: What, Why, and How Disclosures I have nothing to disclose Soo-Jin Cho, MD, PhD Assistant Professor UCSF Dept of Pathology Current Issues in Anatomic Pathology 2017

More information

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Protocol applies primarily to invasive carcinomas and/or associated epithelial lesions, including carcinoma

More information

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of

More information

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic

More information

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa. Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,

More information

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen Plan Incidental finding of a malignant polyp 1. What is a polyp malignant? 2. Role of the pathologist and the endoscopist 3. Quantitative and qualitative risk assessment 4. How to decide what to do? Hubert

More information

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Synonyms. Nephrogenic metaplasia Mesonephric adenoma Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary

More information

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Protocol applies primarily to invasive carcinomas and/or associated epithelial lesions, including carcinoma

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

models; Kaplan meier curves were also extrapolated for each cohort to compare disease specific and overall survival patterns.

models; Kaplan meier curves were also extrapolated for each cohort to compare disease specific and overall survival patterns. ; 21 Urological Oncology MUSCULARIS PROPRIA AND UPSTAGING OF ct1 BLADDER CANCER BADALATO ET AL. BJUI Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect

More information

Histopathology of Melanoma

Histopathology of Melanoma THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 409-416 (1975) Histopathology of Melanoma G. J. WALKER SMITH Department ofpathology, Yale University School ofmedicine, 333 Cedar Street, New Haven, Connecticut

More information

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance & 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series Collecting Cancer Data Bladder & Renal Pelvis NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin 24.06.15 Norman Barrett Smiles [A brief digression - Chair becoming

More information

How Many Diseases in Carcinoma in situ?

How Many Diseases in Carcinoma in situ? How Many Diseases in Carcinoma in situ? Eva Compérat La Pitié Salpêtrière Assistance Publique Université Pierre et Marie Curie, Paris VI Carcinogenesis of Bladder Cancer (BC) BC is a panurothelial disease

More information

Microcystic transitional cell carcinoma: a rare tumor of the urinary bladder

Microcystic transitional cell carcinoma: a rare tumor of the urinary bladder PATHOLOGICA 2017;109:151-155 Case report Microcystic transitional cell carcinoma: a rare tumor of the urinary bladder M. TRIKI 1, L. AYADI 1, R. KALLEL 1, S. CHARFI 1, I. SAGUEM 1, N. MHIRI 2, T.S. BOUDAWARA

More information

A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens

A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens EUROPEAN UROLOGY 63 (2013) 321 332 available at www.sciencedirect.com journal homepage: www.europeanurology.com Collaborative Review Bladder Cancer A Contemporary Update on Pathology Standards for Bladder

More information

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to

More information

GOBLET CELL CARCINOID

GOBLET CELL CARCINOID GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to

More information

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates Staging Challenges in Lower GI Cancers Sanjay Kakar, MD University of California, San Francisco March 05, 2017 Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education

More information

CYSTIC TUMORS OF THE KIDNEY JOHN N. EBLE, M.D. CYSTIC NEPHROMA

CYSTIC TUMORS OF THE KIDNEY JOHN N. EBLE, M.D. CYSTIC NEPHROMA Page 1 CYSTIC TUMORS OF THE KIDNEY JOHN N. EBLE, M.D. Department of Pathology & Laboratory Medicine Phone (317) 274-4806 Medical Science A-128 FAX: (317) 278-2018 635 Barnhill Drive jeble @iupui.edu Indianapolis,

More information

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of

More information

Controversies in the management of Non-muscle invasive bladder cancer

Controversies in the management of Non-muscle invasive bladder cancer Controversies in the management of Non-muscle invasive bladder cancer Sia Daneshmand, MD Associate Professor of Urology (Clinical Scholar) Director of Urologic Oncology Director of Clinical Research Urologic

More information

BJUI. Invasive T1 bladder cancer: indications and rationale for radical cystectomy

BJUI. Invasive T1 bladder cancer: indications and rationale for radical cystectomy 2008 The Authors; Journal compilation 2008 BJU International Mini-review Article INVASIVE T1 BLADDER CANCER: INDICATIONS AND RATIONALE FOR RADICAL CYSTECTOMY STEIN and PENSON BJUI BJU INTERNATIONAL Invasive

More information

Disclosures. The Importance of Pathology? Pathologic, Morphologic and Clinical Features. Pathologic Reproducibility

Disclosures. The Importance of Pathology? Pathologic, Morphologic and Clinical Features. Pathologic Reproducibility The Importance of Pathology? Seth P. Lerner, MD, FACS Beth and Dave Swalm Chair in Urologic Oncology Scott Department of Urology Baylor College of Medicine Support for research Disclosures Photocure, Imalux,

More information

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency World Health Organization Available in Feb 2016 Frame work for reporting Major contributing

More information

Cystoscopy in children presenting with hematuria should not be overlooked

Cystoscopy in children presenting with hematuria should not be overlooked Ped Urol Case Rep 2015; 2(3):7-11 DOI: 10.14534/PUCR.2015310303 PUCR Ped Urol Case Rep PEDIATRIC UROLOGY CASE REPORTS ISSN: 2148 2969 Journal homepage: http://www.pediatricurologycasereports.com Cystoscopy

More information

Case # year old man with a 2 cm right kidney mass

Case # year old man with a 2 cm right kidney mass Case # 4. 52 year old man with a 2 cm right kidney mass Figure 1 Figure 2 Figure 3 Figure 4 Diagnosis: Negative/Non-diagnostic Normal kidney tissue Fine needle aspiration (FNA) of the kidney is performed

More information

Journal of International Academy of Forensic Science & Pathology (JIAFP)

Journal of International Academy of Forensic Science & Pathology (JIAFP) Journal of International Academy of Forensic Science & Pathology (JIAFP) ISSN 2395-0722 MICROCYSTIC ADNEXAL CARCINOMA-A CASE REPORT WITH REVIEW OF LITERATURE Case Report Sulakshana M S 1,Natarajan M 2

More information

Unusual Variants of Bladder Cancer Cristina Magi-Galluzzi, MD, PhD

Unusual Variants of Bladder Cancer Cristina Magi-Galluzzi, MD, PhD Unusual Variants of Bladder Cancer Cristina Magi-Galluzzi, MD, PhD Director of Genitourinary Pathology, Professor of Pathology, Lerner College of Medicine Cleveland Clinic Objectives Update on variants

More information

Large blocks in prostate and bladder pathology

Large blocks in prostate and bladder pathology Large blocks in prostate and bladder pathology Farkas Sükösd Department of Pathology, University of Szeged The history of the large block technique in radical prostatectomy and cystectomy The first large

More information

Spectrum of Lesions in Cystoscopic Bladder Biopsies -A Histopathological Study

Spectrum of Lesions in Cystoscopic Bladder Biopsies -A Histopathological Study AJMS Al Ameen J Med Sci (2 012 )5 (2 ):1 3 2-1 3 6 (A US National Library of Medicine enlisted journal) I S S N 0 9 7 4-1 1 4 3 C O D E N : A A J M B G ORIGI NAL ARTICLE Spectrum of Lesions in Cystoscopic

More information

Inverted (Endophytic) Noninvasive Lesions and Neoplasms of the Urothelium: The Cinderella Group Has Yet to Be Fully Exploited

Inverted (Endophytic) Noninvasive Lesions and Neoplasms of the Urothelium: The Cinderella Group Has Yet to Be Fully Exploited EUROPEAN UROLOGY 59 (2011) 225 230 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial Inverted (Endophytic) Noninvasive Lesions and Neoplasms of the Urothelium: The

More information

Basal cell carcinoma 5/28/2011

Basal cell carcinoma 5/28/2011 Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers

More information

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto Int J Clin Oncol (2013) 18:75 80 DOI 10.1007/s10147-011-0346-8 ORIGINAL ARTICLE Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Clinicopathological Study of Urinary Bladder Neoplasms on Trans Urethral Resected Bladder

More information

E arly clinical observations regarding the biology

E arly clinical observations regarding the biology 91 REVIEW Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies R Montironi, A Lopez-Beltran, R Mazzucchelli, D G Bostwick... The classification and grading

More information